CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 570 enrolled
Drug / intervention
GLUMA (Kulzer GmbH, Germany) desensitizing agentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04248803
NCT04248803N/ACompleted

Efficacy of Gluma Desensitizer in Controlling the Immediate Post-treatment Sensitivity in Etch-and-rinse and Self-etch Adhesive Bonded Occlusal Composite Restorations

Tamil Nadu Dr.M.G.R.Medical University·interventional·Posted Jan 30, 2020·Updated Oct 20, 2025

In Brief

A clinical study evaluating GLUMA (Kulzer GmbH, Germany) desensitizing agent for Sensitivity, Tooth. Completed, enrolled 570 participants across 1 site.

Detailed Summary

To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 30, 2020
Enrollment StartFeb 6, 2020
Primary CompletionFeb 20, 2025
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 6.4 years ago

Interventions

GLUMA (Kulzer GmbH, Germany) desensitizing agentother

GLUMA desensitizer is used to reduce tooth sensitivity